Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Buy
58
LNSR Quote, Financials, Valuation and Earnings
Last price:
$8.63
Seasonality move
:
0.08%
Day range:
$8.60 - $8.95
52-week range:
$2.67 - $9.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.03x
P/B ratio:
4.44x
Volume:
57K
Avg. volume:
50.9K
1-year change:
115.1%
Market cap:
$100.9M
Revenue:
$42.2M
EPS (TTM):
-$1.46
Analysts' Opinion
-
Consensus RatingLENSAR has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, LENSAR has an estimated upside of 26.58% from its current price of $8.69.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $8.69.
Fair Value
-
According to the consensus of 0 analysts, LENSAR has 26.58% upside to fair value with a price target of -- per share.
LNSR vs. S&P 500
-
Over the past 5 trading days, LENSAR has overperformed the S&P 500 by 1.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
LENSAR does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
LENSAR has grown year-over-year revenues for 6 quarters straight. In the most recent quarter LENSAR reported revenues of $13.5M.
Earnings Growth
-
LENSAR has grown year-over-year earnings for 0 quarters straight. In the most recent quarter LENSAR reported earnings per share of -$0.13.
Enterprise value:
82.9M
EV / Invested capital:
--
Price / LTM sales:
2.03x
EV / EBIT:
--
EV / Revenue:
1.70x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$23.9M
Return On Assets:
-25.19%
Net Income Margin (TTM):
-34.03%
Return On Equity:
-56.16%
Return On Invested Capital:
-56.16%
Operating Margin:
-9.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $36.3M | $40.3M | $48.9M | $9.8M | $13.5M | |
| Gross Profit | $19.1M | $22.4M | $23.9M | $4.9M | $6.3M | |
| Operating Income | -$21.5M | -$11.9M | -$8.6M | -$2M | -$1.2M | |
| EBITDA | -$18.2M | -$8.4M | -$4.9M | -$1.2M | -$239K | |
| Diluted EPS | -$2.14 | -$1.68 | -$1.46 | -$0.23 | -$0.13 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $60M | $46.7M | $32.2M | $48.6M | $39.4M | |
| Total Assets | $80.7M | $68.1M | $54.8M | $70.9M | $62M | |
| Current Liabilities | $8.3M | $8M | $9.8M | $11M | $11.7M | |
| Total Liabilities | $11.8M | $11.1M | $12.2M | $34.5M | $39.3M | |
| Total Equity | $68.9M | $57M | $42.6M | $36.4M | $22.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10.8M | -$13.9M | -$6.4M | -$339K | $3.2M | |
| Cash From Investing | -$214K | -$248K | -$8.1M | -$2K | -$905K | |
| Cash From Financing | -- | $19.8M | $52K | -$205K | -$93K | |
| Free Cash Flow | -$11.1M | -$14.2M | -$6.6M | -$341K | $3.1M | |
LNSR
Sector
Market Cap
$100.9M
$48.6M
Price % of 52-Week High
94.15%
47.39%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
115.1%
-33.25%
Beta (5-Year)
--
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$8.51
200-day SMA
Buy
Level
$5.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$7.96
Relative Strength Index (RSI14)
Buy
Level
62.80
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-25.7143
50-day SMA
Buy
Level
$7.17
MACD (12, 26)
Buy
Level
0.44
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.9651)
Sell
CA Score
(Annual)
Level (-0.6155)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.4735)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
Stock Forecast FAQ
In the current month, LNSR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LNSR average analyst price target in the past 3 months is --.
-
Where Will LENSAR Stock Be In 1 Year?
According to analysts, the consensus estimate is that LENSAR share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About LENSAR?
Analysts are divided on their view about LENSAR share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that LENSAR is a Sell and believe this share price will drop from its current level to --.
-
What Is LENSAR's Price Target?
The price target for LENSAR over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LNSR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for LENSAR is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LNSR?
You can purchase shares of LENSAR via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase LENSAR shares.
-
What Is The LENSAR Share Price Today?
LENSAR was last trading at $8.63 per share. This represents the most recent stock quote for LENSAR. Yesterday, LENSAR closed at $8.69 per share.
-
How To Buy LENSAR Stock Online?
In order to purchase LENSAR stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 4
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
85
BMA alert for Jan 4
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
47
AGFY alert for Jan 4
Agrify [AGFY] is down 5.86% over the past day.
